Skip to main content

Closed

TLSI: TriSalus Life Sciences, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-62.4%

ROIC-47.2%

Financially safe

Stretched

Debt / equity2.69×

Interest coverage-4.9×

Current ratio5.78×

TriSalus Life Sciences, Inc.

TLSINASDAQ Global Market·USD·Closed

TriSalus Life Sciences, Inc.

TLSINASDAQ·USD·Closed

$4.54

−0.44%

$4.54

−$0.02 (0.44%)

52W Range

41thpctl

Volume

0.39×avg

Mkt Cap

172.11MUSD

P/E

-3.2TTM

Div Yield

–ann

52W Range

41thpctl

Volume

0.39×avg

Market Cap

172.11MUSD

P/E Ratio

-3.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings